According to the 2020 PNV Assessment Report, released today, between October (when it was included) and December of last year, approximately 34,000 first doses of HPV vaccine were given to boys and nearly 90,000 doses of the vaccine against HPV. Against meningitis B for children under the age of two.
Despite the epidemic, despite two million vaccines against influenza, despite everything, there are still more than 90,000 against meningococcal B disease and 34,000 against HPV in boys. “We think it was very good,” said PNV director of Lusa Teresa Fernandez.
“PNV has been really strong and still is as strong as before (…) [a pandemia] It was a very big test of fire, “he added.
Both vaccination against human papillomavirus (HPV) and giving the vaccine against meningitis B to all children born from 2019 (it was only for high-risk groups) began to include PNV last year and began its administration in October. In the case of HPV in boys, it includes those born in 2009.
The 2020 PNV bulletin released today states that “cohorts covered by these vaccines will continue to be vaccinated through 2021 and beyond.”
The document also contains data regarding the administration of the vaccine against HPV infection in girls, which has been present in PNV since 2008, but has already undergone changes in the recommended age, which was from 10 to 13 years (between October 2014 and December 2016) And he turned 10 years old (January 2017).
The groups (cohorts) subject to the analysis began vaccination between 2016 and 2019 (which were completed in 2020, with the ages of 11-14 years old). During this period, there was a change in the recommended age for the start of vaccination: between October 2014 and December 2016, she was 10-13 years old.
According to the circular, all cohorts analyzed had reached vaccination coverage greater than or equal to 92% for the first dose of HPV vaccine. For the second dose, the group born in 2009 (vaccination still ongoing) did not reach the target of 85%.
The document adds that, from the age of 12 (the 2008 group and earlier), 91% to 95% of girls have already completed the recommended scheme.
In addition to the inclusion of the HPV vaccine in boys and the meningitis B vaccine, the HPV vaccine has undergone other changes, including the introduction of a vaccine against rotavirus, which is the main cause of gastroenteritis in children, which is applied to high-risk groups. .
Changes have also been made in vaccination against tetanus and diphtheria in women of childbearing age, who began taking at least three doses.
The vaccination against influenza B virus, a treatment program that started after 12 months of age, began with a single dose. 11 months.
In the case of the measles, mumps and rubella (VASPR) vaccine, the recommended time interval between the two doses is now six months, for travelers born in 1970 and from now on, two doses of the measles vaccine are now recommended. Health professionals have also started recommending two doses of this vaccine.
Also among the changes made to PNV is the free hepatitis B vaccine for all health system professionals, as long as they do not possess strict management functions.
In the BCG vaccine, it is recommended that high-risk groups in the maternity hospital be vaccinated for newborns identified at birth.